Literature DB >> 27717244

Telomere content measurement in human hematopoietic cells: Comparative analysis of qPCR and Flow-FISH techniques.

Taylor Wand1, Mike Fang2, Christina Chen2, Nathan Hardy2, J Philip McCoy3, Bogdan Dumitriu2, Neal S Young1,2, Angélique Biancotto4.   

Abstract

Abnormal telomere lengths have been linked to cancer and other hematologic disorders. Determination of mean telomere content (MTC) is traditionally performed by Southern blotting and densitometry, giving a mean telomere restriction fragment (TRF) value for the total cell population studied. Here, we compared a quantitative Polymerase Chain Reaction approach (qPCR) and a flow cytometric approach, fluorescence in situ hybridization (Flow-FISH), to evaluate telomere content distribution in total patient peripheral blood mononuclear cells or specific cell populations. Flow-FISH is based on in situ hybridization using a fluorescein-labeled peptide nucleic acid (PNA) (CCCTAA)3 probe and DNA staining with propidium iodide. We showed that both qPCR and Flow-FISH provide a robust measurement, with Flow-FISH measuring a relative content longer than qPCR at a single cell approach and that TRF2 fluorescence intensity did not correlate with MTC. Both methods showed comparable telomere content reduction with age, and the rate of relative telomere loss was similar. Published 2016 Wiley Periodicals Inc. This article is a US government work and, as such, is in the public domain in the United States of America. Published 2016 Wiley Periodicals Inc. This article is a US government work and, as such, is in the public domain in the United States of America.

Entities:  

Keywords:  Flow-FISH; TRF2; qPCR; telomere

Mesh:

Substances:

Year:  2016        PMID: 27717244      PMCID: PMC6482817          DOI: 10.1002/cyto.a.22982

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  39 in total

1.  Limited telomere shortening in hematopoietic stem cells after transplantation.

Authors:  T H Brümmendorf; N Rufer; G M Baerlocher; E Roosnek; P M Lansdorp
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

2.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

3.  Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH.

Authors:  Gabriela M Baerlocher; Peter M Lansdorp
Journal:  Cytometry A       Date:  2003-09       Impact factor: 4.355

4.  Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.

Authors:  T H Brümmendorf; T L Holyoake; N Rufer; M J Barnett; M Schulzer; C J Eaves; A C Eaves; P M Lansdorp
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

5.  Telomere length measurements using fluorescence in situ hybridization and flow cytometry.

Authors:  Gabriela M Baerlocher; Peter M Lansdorp
Journal:  Methods Cell Biol       Date:  2004       Impact factor: 1.441

6.  Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls.

Authors:  Gabriela M Baerlocher; Jennifer Mak; Teri Tien; Peter M Lansdorp
Journal:  Cytometry       Date:  2002-02-01

7.  Mammalian meiotic telomeres: protein composition and redistribution in relation to nuclear pores.

Authors:  H Scherthan; M Jerratsch; B Li; S Smith; M Hultén; T Lock; T de Lange
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

8.  Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma.

Authors:  J K Griffith; J E Bryant; C A Fordyce; F D Gilliland; N E Joste; R K Moyzis
Journal:  Breast Cancer Res Treat       Date:  1999-03       Impact factor: 4.872

9.  Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders.

Authors:  T H Brümmendorf; N Rufer; T L Holyoake; J Maciejewski; M J Barnett; C J Eaves; A C Eaves; N Young; P M Lansdorp
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

10.  Association between outcome and telomere DNA content in prostate cancer.

Authors:  L Donaldson; C Fordyce; F Gilliland; A Smith; R Feddersen; N Joste; R Moyzis; J Griffith
Journal:  J Urol       Date:  1999-11       Impact factor: 7.450

View more
  4 in total

1.  Telomere attrition in heart failure: a flow-FISH longitudinal analysis of circulating monocytes.

Authors:  Iris Teubel; Elena Elchinova; Santiago Roura; Marco A Fernández; Carolina Gálvez-Montón; Pedro Moliner; Marta de Antonio; Josep Lupón; Antoni Bayés-Genís
Journal:  J Transl Med       Date:  2018-02-20       Impact factor: 5.531

2.  Cell cycle-dependent and -independent telomere shortening accompanies murine brain aging.

Authors:  Quratul Ain; Christian Schmeer; Diane Penndorf; Mike Fischer; Tzvetanka Bondeva; Martin Förster; Ronny Haenold; Otto W Witte; Alexandra Kretz
Journal:  Aging (Albany NY)       Date:  2018-11-20       Impact factor: 5.682

3.  Contrasting seasonal patterns of telomere dynamics in response to environmental conditions in the ectothermic sand lizard, Lacerta agilis.

Authors:  Jannike Axelsson; Erik Wapstra; Emily Miller; Nicky Rollings; Mats Olsson
Journal:  Sci Rep       Date:  2020-01-13       Impact factor: 4.379

4.  Method comparison studies of telomere length measurement using qPCR approaches: A critical appraisal of the literature.

Authors:  Alyssa R Lindrose; Lauren W Y McLester-Davis; Renee I Tristano; Leila Kataria; Shahinaz M Gadalla; Dan T A Eisenberg; Simon Verhulst; Stacy Drury
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.